Carisma Therapeutics
Philadelphia, United States · Founded 2016 · $142.0M raised
- Headquarters
- Philadelphia, Pennsylvania
- Founded
- 2016
- Business Model
- B2B
- Website
- carismatx.com
- Total Funding
- $142.0M
- Last Round
- $30.0M Series CSep 2022
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Carisma Therapeutics is a clinical-stage biopharmaceutical company developing cell therapies based on engineered macrophages and monocytes. Its proprietary platform uses chimeric antigen receptors to direct these innate immune cells against tumor-associated antigens, with initial programs targeting solid tumors. The platform was developed in collaboration with the University of Pennsylvania and is intended to create immunotherapies for cancer and other serious diseases.
Summary
Carisma Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2016. It has raised $142.0M in total across 3 rounds, most recently a $30.0M Series C round in Sep 2022. Investors include SymBiosis II, AbbVie Ventures and HealthCap.
Funding History
Sep 2022
Sign up to see all 3 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/carisma-therapeutics"><img src="https://indexed.vc/api/badge/company/carisma-therapeutics" alt="Carisma Therapeutics on Indexed.vc" width="260" height="76" /></a>